Suppr超能文献

左心室致密化不全的肾功能障碍和结局。

Renal dysfunction and outcome in left ventricular non-compaction.

机构信息

Department of Cardiology, University Heart Center Zurich, Switzerland.

Department of Cardiology, University Hospital Basel, Switzerland.

出版信息

Cardiol J. 2023;30(5):781-789. doi: 10.5603/CJ.a2022.0105. Epub 2022 Nov 17.

Abstract

BACKGROUND

While renal function has been observed to inversely correlate with clinical outcome in other cardiomyopathies, its prognostic significance in patients with left ventricular non-compaction cardiomyopathy (LVNC) has not been investigated. The aim of this study was to determine the prognostic value of renal function in LVNC patients.

METHODS

Patients with isolated LVNC as diagnosed by echocardiography and/or magnetic resonance imaging in 4 Swiss centers were retrospectively analyzed for this study. Values for creatinine, urea, and estimated glomerular filtration rate (eGFR) as assessed by the CKD-EPI 2009 formula were collected and analyzed by a Cox regression model for the occurrence of a composite endpoint (death or heart transplantation).

RESULTS

During the median observation period of 7.4 years 23 patients reached the endpoint. The ageand gender-corrected hazard ratios (HR) for death or heart transplantation were: 1.9 (95% confidence interval [CI] 1.4-2.6) for each increase over baseline creatinine level of 30 μmol/L (p < 0.001), 1.6 (95% CI 1.2-2.2) for each increase over baseline urea level of 5 mmol/L (p = 0.004), and 3.6 (95% CI 1.9-6.9) for each decrease below baseline eGFR level of 30 mL/min (p ≤ 0.001). The HR (log2) for every doubling of creatinine was 7.7 (95% CI 3-19.8; p < 0.001), for every doubling of urea 2.5 (95% CI 1.5-4.3; p < 0.001), and for every bisection of eGFR 5.3 (95% CI 2.4-11.6; p < 0.001).

CONCLUSIONS

This study provides evidence that in patients with LVNC impairment in renal function is associated with an increased risk of death and heart transplantation suggesting that kidney function assessment should be standard in risk assessment of LVNC patients.

摘要

背景

虽然肾功能与其他心肌病的临床预后呈负相关,但在左心室心肌致密化不全(LVNC)患者中的预后意义尚未得到研究。本研究旨在确定肾功能在 LVNC 患者中的预后价值。

方法

本研究回顾性分析了瑞士 4 家中心通过超声心动图和/或磁共振成像诊断的孤立性 LVNC 患者。收集了血肌酐、尿素和通过 CKD-EPI 2009 公式评估的估算肾小球滤过率(eGFR)的值,并通过 Cox 回归模型分析了发生复合终点(死亡或心脏移植)的情况。

结果

在中位观察期 7.4 年内,23 例患者达到终点。每增加 30μmol/L 血肌酐水平,死亡或心脏移植的年龄和性别校正风险比(HR)为 1.9(95%置信区间 [CI] 1.4-2.6)(p<0.001),每增加 5mmol/L 血尿素水平,HR 为 1.6(95%CI 1.2-2.2)(p=0.004),每降低 30ml/min 基线 eGFR 水平,HR 为 3.6(95%CI 1.9-6.9)(p≤0.001)。血肌酐每增加 1 倍的 HR(log2)为 7.7(95%CI 3-19.8;p<0.001),血尿素每增加 1 倍的 HR 为 2.5(95%CI 1.5-4.3;p<0.001),eGFR 每减半的 HR 为 5.3(95%CI 2.4-11.6;p<0.001)。

结论

本研究提供的证据表明,在 LVNC 患者中,肾功能受损与死亡和心脏移植风险增加相关,这表明在 LVNC 患者的风险评估中应常规进行肾功能评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84e7/10635721/5ef2fa214ab8/cardj-30-5-781f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验